C E Margo1. 1. Department of Ophthalmology, Watson Clinic, LLP, Lakeland, Florida 33805, USA.
Abstract
PURPOSE: To determine the accuracy, specificity, and sensitivity of the clinical diagnosis of malignant tumor of the eyelid. METHOD: Analysis of consecutively submitted biopsy specimens of the eyelid for 1 year to a regional ophthalmic pathology laboratory. RESULTS: Agreement was noted between clinical and histopathologic diagnoses on 72 (84%) of 86 eyelid biopsy specimens received over 12 months. Ten (11.6%) clinical diagnoses of suspected malignant eyelid tumor showed benign skin conditions, and four (4.6%) clinical diagnoses of presumed benign conditions proved to be malignant. CONCLUSIONS: The clinical assessment of eyelid malignancy by ophthalmologists is reasonably good when evaluated in terms of sensitivity (87.5%) and specificity (81.5%) of diagnosis. Lesions giving rise to the false-negative diagnosis of malignancy tend to be nodules with unremarkable surface features.
PURPOSE: To determine the accuracy, specificity, and sensitivity of the clinical diagnosis of malignant tumor of the eyelid. METHOD: Analysis of consecutively submitted biopsy specimens of the eyelid for 1 year to a regional ophthalmic pathology laboratory. RESULTS: Agreement was noted between clinical and histopathologic diagnoses on 72 (84%) of 86 eyelid biopsy specimens received over 12 months. Ten (11.6%) clinical diagnoses of suspected malignant eyelid tumor showed benign skin conditions, and four (4.6%) clinical diagnoses of presumed benign conditions proved to be malignant. CONCLUSIONS: The clinical assessment of eyelid malignancy by ophthalmologists is reasonably good when evaluated in terms of sensitivity (87.5%) and specificity (81.5%) of diagnosis. Lesions giving rise to the false-negative diagnosis of malignancy tend to be nodules with unremarkable surface features.
Authors: Sofia Karachrysafi; Georgios Fadel; Viktoria Kapourani; Fani Akritidou; Pinelopi Anastasiadou; Theodora Papamitsou; Antonia Sioga; Elie Fadel Journal: SAGE Open Med Case Rep Date: 2022-05-11